Pilot Study of Patient Navigation for Kidney Stone Patients After ED Visits

ConditionKidney Stones
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, San Francisco

About this trial

Patients who visit the emergency department for kidney stones are sometimes referred to urology for follow-up care but never complete that visit. Missing follow-up appointments can lead to worse outcomes, including recurrent pain, infection, or surgery. Research shows that patients who are socially or economically at risk (such as those with public insurance, lower income, or limited English proficiency) are more likely to experience these care gaps.

This study will pilot a patient navigation program designed to help patients with urinary stone disease (USD) attend their scheduled urology appointments after being seen in the Emergency Department. Using an electronic health record (EHR) based prediction model developed in earlier research, patients at higher risk for being lost to follow-up will be identified and invited to participate. Each participant will be paired with a trained patient navigator who will assess barriers to care, provide support, and maintain contact for about 12 weeks.

The goal of this study is to evaluate the outcomes and feasibility of this navigation intervention. Findings will help determine whether a larger study should test if this approach improves access to care and health outcomes for patients with kidney stones.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Presentation to the Emergency Department with urinary stone disease

Placement of an outpatient urology referral from the Emergency Department

Identified as high risk for loss to follow-up based on the study's screening process

Disqualifiers

Age < 18 years

Unable to provide informed consent

Non-English-speaking

No outpatient urology referral placed from the Emergency Department

Trial design

Treatments tested in this trial

  • Patient Navigation

Treatment groups

31 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of California, San Francisco

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator